Market Overview:
The global gene therapy market reached a value of US$ 3.77 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.5 Billion by 2027 exhibiting a growth rate (CAGR) of 15.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Gene therapy is a technique for preventing disease progression by modifying the expression of mutated genes or altering the biological properties of living cells for therapeutic use. It improves the ability of the body to fight against a wide range of diseases, such as cancer, diabetes, hemophilia, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). Nowadays, a wide variety of gene therapy products are available worldwide, which include viral vectors, bacterial vectors, plasmid deoxyribonucleic acid (DNA), human gene-editing technology, and patient-derived cellular gene therapy.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Gene Therapy Market Trends:
The growing prevalence of inherited diseases and acquired disorders, in confluence with easy access to healthcare facilities, represents one of the key factors catalyzing the demand for gene therapy to improve the quality of life of patients. Moreover, the rising cases of genetic disorders, such as muscular dystrophy and cystic fibrosis, in children and young adults are bolstering the market growth. In line with this, the increasing geriatric population, which is more susceptible to develop infectious diseases on account of inappropriate gene activity, is contributing to the market growth. Apart from this, the development of new gene therapy that offers a safer, non-addictive alternative to opioids in treating a broad range of chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, is favoring the market growth. In addition, a large variety of therapeutic genes are under investigation, including tumor suppressor, anti-angiogenesis, inflammatory cytokine, and micro ribonucleic acid (RNA) genes. These genes can assist in treating cancer, leukemia, severe combined immune deficiency, and blindness caused by retinitis pigmentosa, which is anticipated to stimulate the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gene therapy market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on gene type, vector type, delivery method and application.
Breakup by Gene Type:
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide Gene
- Deficiency
- Growth Factors
- Receptors
- Others
Breakup by Vector Type:
- Viral Vector
- Adenoviruses
- Lentiviruses
- Retroviruses
- Adeno-Associated Virus
- Herpes Simplex Virus
- Poxvirus
- Vaccinia Virus
- Others
- Non-Viral Techniques
- Naked and Plasmid Vectors
- Gene Gun
- Electroporation
- Lipofection
- Others
Breakup by Delivery Method:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- In-Vivo Gene Therapy
- Ex-Vivo Gene Therapy
Breakup by Application:
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bluebird Bio Inc., Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Orchard Therapeutics plc, UniQure N.V. and Voyager Therapeutics Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Gene Type, Vector Type, Delivery Method, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bluebird Bio Inc., Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Orchard Therapeutics plc, UniQure N.V. and Voyager Therapeutics Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gene Therapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Gene Type
6.1 Antigen
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cytokine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Tumor Suppressor
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Suicide Gene
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Deficiency
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Growth Factors
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Receptors
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Vector Type
7.1 Viral Vector
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Adenoviruses
7.1.2.2 Lentiviruses
7.1.2.3 Retroviruses
7.1.2.4 Adeno-Associated Virus
7.1.2.5 Herpes Simplex Virus
7.1.2.6 Poxvirus
7.1.2.7 Vaccinia Virus
7.1.2.8 Others
7.1.3 Market Forecast
7.2 Non-Viral Techniques
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Naked and Plasmid Vectors
7.2.2.2 Gene Gun
7.2.2.3 Electroporation
7.2.2.4 Lipofection
7.2.2.5 Others
7.2.3 Market Forecast
8 Market Breakup by Delivery Method
8.1 In-Vivo Gene Therapy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ex-Vivo Gene Therapy
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Oncological Disorders
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Rare Diseases
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cardiovascular Diseases
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Neurological Disorders
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Infectious Disease
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abeona Therapeutics Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Adaptimmune Therapeutics plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Adverum Biotechnologies Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Amgen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Astellas Pharma Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Biogen Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Bluebird Bio Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Mustang Bio Inc. (Fortress Biotech Inc.)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novartis AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Orchard Therapeutics plc
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 UniQure N.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Voyager Therapeutics Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
List of Figures
Figure 1: Global: Gene Therapy Market: Major Drivers and Challenges
Figure 2: Global: Gene Therapy Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Gene Therapy Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Gene Therapy Market: Breakup by Gene Type (in %), 2021
Figure 5: Global: Gene Therapy Market: Breakup by Vector Type (in %), 2021
Figure 6: Global: Gene Therapy Market: Breakup by Delivery Method (in %), 2021
Figure 7: Global: Gene Therapy Market: Breakup by Application (in %), 2021
Figure 8: Global: Gene Therapy Market: Breakup by Region (in %), 2021
Figure 9: Global: Gene Therapy (Antigen) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Gene Therapy (Antigen) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Gene Therapy (Cytokine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Gene Therapy (Cytokine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Gene Therapy (Tumor Suppressor) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Gene Therapy (Tumor Suppressor) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Gene Therapy (Suicide Gene) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Gene Therapy (Suicide Gene) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Gene Therapy (Deficiency) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Gene Therapy (Deficiency) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Gene Therapy (Growth Factors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Gene Therapy (Growth Factors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Gene Therapy (Receptors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Gene Therapy (Receptors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Gene Therapy (Other Gene Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Gene Therapy (Other Gene Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Gene Therapy (Viral Vector) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Gene Therapy (Viral Vector) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Gene Therapy (Non-Viral Techniques) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Gene Therapy (Non-Viral Techniques) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Gene Therapy (In-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Gene Therapy (In-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Gene Therapy (Oncological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Gene Therapy (Oncological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Gene Therapy (Rare Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Gene Therapy (Rare Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Gene Therapy (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Gene Therapy (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Gene Therapy (Neurological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Gene Therapy (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Gene Therapy (Infectious Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Gene Therapy (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Gene Therapy (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Gene Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: North America: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: North America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United States: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: United States: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Canada: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Canada: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Asia-Pacific: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Asia-Pacific: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: China: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: China: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Japan: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Japan: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: India: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: India: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: South Korea: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: South Korea: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Australia: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Australia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Indonesia: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Indonesia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Europe: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Europe: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Germany: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Germany: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: France: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: France: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: United Kingdom: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: United Kingdom: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Italy: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Italy: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Spain: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Spain: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Russia: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Russia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Others: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Latin America: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Latin America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Brazil: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Brazil: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Mexico: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Mexico: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Others: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Middle East and Africa: Gene Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Middle East and Africa: Gene Therapy Market: Breakup by Country (in %), 2021
Figure 93: Middle East and Africa: Gene Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Global: Gene Therapy Industry: SWOT Analysis
Figure 95: Global: Gene Therapy Industry: Value Chain Analysis
Figure 96: Global: Gene Therapy Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Gene Therapy Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Gene Therapy Market Forecast: Breakup by Gene Type (in Million US$), 2022-2027
Table 3: Global: Gene Therapy Market Forecast: Breakup by Vector Type (in Million US$), 2022-2027
Table 4: Global: Gene Therapy Market Forecast: Breakup by Delivery Method (in Million US$), 2022-2027
Table 5: Global: Gene Therapy Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Gene Therapy Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Gene Therapy Market: Competitive Structure
Table 8: Global: Gene Therapy Market: Key Players